Info@ThinkPinkRocks.com

Posts Tagged drug-discovery

MSK Plays Critical Role in FDA Approval of New Melanoma Drug

Add a Comment By Jim Stallard, MA, Writer/Editor   |  Tuesday, January 6, 2015 A new treatment for advanced melanoma is the latest promising advance in immunotherapy tested in large part by our scientists.

For More........

Clearing Up Clinical Trials: Myths and Misconceptions

Add a Comment By Esther Napolitano, BS, Science Writer/Editor   |  Monday, October 20, 2014 Medical oncologist Paul Sabbatini demystifies common misconceptions surrounding clinical trials. read more

For More........

What Is Epigenetics?

1 comment By Julie Grisham, MS, Science Writer/Editor   |  Tuesday, October 14, 2014 Physician-scientist Omar Abdel-Wahab explains epigenetics, a growing field based on the study of genetic changes that are not part of the DNA code, and how it relates to cancer. read more

For More........

Prostate Cancer Organoids Provide New Tool for Evaluating Therapies

Add a Comment By Julie Grisham, MS, Science Writer/Editor   |  Thursday, September 4, 2014 Researchers have created tiny structures called organoids from patients’ prostate tumors. These organoids will allow the study of tumors in greater detail and enable correlation of genetic mutations with drug response

For More........

Compound from Tropical Plant Targets Key Cancer-Causing Genes

1 comment By Julie Grisham, MS, Science Writer/Editor   |  Monday, July 28, 2014 Memorial Sloan Kettering researchers have found a naturally occurring compound that can destroy cancer cells in mice by targeting MYC , a cancer-causing gene that has remained elusive until now. read more

For More........

Hsp90: A Very Promising Target for Cancer Therapy

Add a Comment By Celia Gittelson, BA  |  Thursday, July 17, 2014 A small molecule discovered at MSK called PU-H71 blocks the growth of cancer cells and enables doctors to image tumors. read more

For More........

Innovative Partnership Will Speed Drug Discovery and Development

1 comment By Jim Stallard, MA, Writer/Editor   |  Friday, October 25, 2013 Memorial Sloan-Kettering is joining with two other academic institutions in a pioneering collaboration to speed early-stage drug discoveries into therapies for patients.

For More........
Page 1 of 212